Skip to main content

Alignment Healthcare Inc

For the period ended Dec 31, 2024. Filed Feb 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 27, 2025

ALHC$7.27-1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Alignment Healthcare, Inc.
Date: February 27, 2025By:/s/ John Kao
John Kao
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

SignatureTitleDate
/s/ John KaoChief Executive Officer (Principal Executive Officer)February 27, 2025
John Kao
/s/ Thomas FreemanChief Financial Officer (Principal Financial Officer)February 27, 2025
Thomas Freeman
/s/ Joseph KonowieckiChairman of the BoardFebruary 27, 2025
Joseph Konowiecki
/s/ Jody BilneyDirectorFebruary 27, 2025
Jody Bilney
/s/ David HodgsonDirectorFebruary 27, 2025
David Hodgson
/s/ Yon JordenDirectorFebruary 27, 2025
Yon Jorden
/s/ Jacqueline KosecoffDirectorFebruary 27, 2025
Jacqueline Kosecoff
/s/ Margaret McCarthyDirectorFebruary 27, 2025
Margaret McCarthy
/s/ Mark McClellanDirectorFebruary 27, 2025
Mark McClellan
/s/ Robbert VorhoffDirectorFebruary 27, 2025
Robbert Vorhoff
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.